What Is Intercure Ltd. (INCR) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Intercure Ltd.'s intrinsic value is estimated at a composite $1.17, showing conflicting signals at the current price of $0.96. While the average implied return is +22.3%, model disagreement is elevated with a gap of +329.8% between the most bullish and bearish estimates. The most optimistic model, Regime Cross, places fair value at $3.19 (+234.5%), while Dynamic NAV — the most conservative — estimates $0.04 (-95.4%). This +329.8% gap reflects genuine analytical uncertainty about Intercure Ltd.'s intrinsic worth.
What Do the Models Say About INCR?
10 of 13 models are currently active for INCR. Of these, 4 models suggest upside while 6 models suggest overvaluation. The Bayesian DCF estimates INCR's intrinsic value at $0.23, implying -76.1% downside from the current price. See which stocks rank higher →
How Does INCR Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, INCR ranks #90 by Quality of Company score. CirclFi's QOC score of 6.4/10 evaluates 32 fundamental signals. A score of 6.4 indicates above-average quality.
See all Most Undervalued Pharmaceutical Preparations Stocks →
Intercure Ltd.'s positioning within the Pharmaceutical Preparations segment means that pipeline depth and stage distribution plays an outsized role in fundamental analysis. The sector's unique characteristics — including orphan drug designation — shape both the opportunity set and risk profile.
Is INCR a Value Trap?
The Value Trap algorithm is not active for INCR. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
10 of 13 models are active for Intercure Ltd.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, Intercure Ltd. earns a quality score of 6.4/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.
The gap between the most bullish and bearish model spans +329.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every INCR valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across INCR's 10 active models, average confidence is 14%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad